Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

(OP:AIMN)

0.0015 -0.0008 (-34.78%)
Delayed Quote Updated: 11:24 AM EDT, Oct 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 12,869,404
Open 0.0020
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0023
Today's Range 0.0015 - 0.0023
52wk Range 0.0005 - 0.3095
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Your Patients Know Your Name, But Does AI? AimwellBio Expands Its Healthcare Platform and Invites the Public to Nominate Professionals Worth Knowing
New website experience lets practices see which providers AI names in their communities, while AimwellBio expands its professional visibility, verification, intelligence and healthcare-feature... 
From Aimwell Partners
Via ACCESS Newswire
News headline image
After One Clinic Said Yes, the Phone Started Ringing. AIMN Opens Applications for Practices to Be Featured Next.
Aimwell Partners reports inbound interest following its VitalCare of Shelton announcement and invites physicians and healthcare businesses to join its intelligence network. 
From Aimwell Partners
Via ACCESS Newswire

Performance

52-Week Range 99.5% below 52-week high
0.0015
0.0052W Low 0.3152W High
1 Week 62.5% below 1-week high
0.001W Low 0.001W High

(AIMN) traded between $0.00 and $0.31 over the past 52 weeks and last traded at $0.00, 99.5% below its 52-week high. Over the past week it ranged between $0.00 and $0.00.

Past 12 Months
-16.7%
+50.0%
-54.5%
-96.5%
-97.3%
-97.3%
1W -$0.00
1M +$0.00
3M -$0.00
6M -$0.04
YTD -$0.05
1Y -$0.05

AIMN was -97.3% over the past year, -96.5% over six months, -97.3% year to date, -16.7% in the last week.

12 Months vs Market
AIMN
-97.3%
DIA
+12.2%
SPY
+14.6%
QQQ
+17.6%
IWM
+11.2%

Over the past 12 months AIMN returned -97.3% versus DIA (Dow) +12.2%, SPY (S&P 500) +14.6%, QQQ (Nasdaq 100) +17.6% and IWM (Russell 2000) +11.2%.

Volume & Liquidity 2.32× 3-mo avg
Today 12,869,404 3-mo avg 5.5M
1W
22.3M
1M
10.5M
3M
5.5M
6M
3.3M
YTD
3.1M
1Y
3.1M

AIMN most recently traded 12,869,404 shares against a 3-month average daily volume of 5.5M.

More News

Read More
News headline image
The People Verifying Your Healthcare Should Not Be the People Selling It. AimwellBio Launches Provider Verification Registry in Connecticut.
From Aimwell Partners
Via ACCESS Newswire
News headline image
Patients Are Asking AI About Their Health; AimwellBio Wants Verified Physicians to Be Part of the Answer
From Aimwell Partners
Via ACCESS Newswire
News headline image
The GLP-1 Era Has a Trust Problem - AimwellBio is Building the Physician Network to Solve It
From Aimwell Partners
Via ACCESS Newswire
News headline image
AimwellBio Puts Its Global Intelligence Map in Public View, No Login Required, as Dr. Chris A. Jones Builds Out the Advisory Bench Behind it
From Aimwell Partners
Via ACCESS Newswire
News headline image
The IP Was Only Half the Acquisition: Aimwell Bio Closes the Trustr IP Purchase and Begins Bringing Aboard the People Who Built It
From Aimwell Partners
Via ACCESS Newswire
News headline image
AimwellBio Secures Patented Behavioral AI Portfolio Backed by Oxford Science and Sanofi Pilot; Inventor Dr. Chris A. Jones Joins Board of Advisors
From Aimwell Partners
Via ACCESS Newswire
News headline image
AimwellBio Publishes Investor Briefing on Acquired Trustr Intellectual Property Portfolio Valued at $10m Reinforcing Commitment to Transparency
From Aimwell Partners
Via ACCESS Newswire
News headline image
Aimwell Partners Announces Agreement in Principle to Acquire Intellectual Property Valued at Approximately $10 Million
From Aimwell Partners
Via ACCESS Newswire
News headline image
The World's Most Valuable Healthcare Database May Already Exist, The Problem Is Nobody Knows Who to Trust Inside It
From Aimwell Partners
Via ACCESS Newswire
News headline image
Aimwell Partners Inc. (OTC: AIMN) Opens No-Cost Observer Access and Publishes The Standard Behind Its Verified Intelligence Platform
From Aimwell Partners
Via ACCESS Newswire
News headline image
The Doctors Who Actually Know Things Have Spent Twenty Years Being Cited and Never Credited. Aimwell Partners Inc. Is Building the Network That Puts Their Names on the Record
From Aimwell Partners
Via ACCESS Newswire
News headline image
Aimwell Partners Inc. (OTC:AIMN) Confirms Advanced Discussions With Curated Life Sciences Capital Network
From Aimwell Partners
Via ACCESS Newswire
News headline image
Aimwell Partners Inc. (OTC: AIMN) Enters Final Negotiations to Acquire Healthcare Intellectual Property Independently Valued at $10 Million
From Aimwell Partners
Via ACCESS Newswire
News headline image
The Professionals Arrived First - Now Their Institutions are Following: Aimwell Partners Inc. Confirms Enterprise Interest Driven by Its Credentialed Observer Network
From Aimwell Partners
Via ACCESS Newswire
News headline image
Every AI Intelligence Platform Asks the Market to Trust Its Numbers. Aimwell Partners Inc. (OTC:AIMN) Just Opened the Data
From Aimwell Partners
Via ACCESS Newswire
News headline image
Aimwell Partners Inc. Publishes the Adversarial Validation Standard, v1, an Open Methodology Framework for Verifying AI-Generated Biopharma Intelligence
From Aimwell Partners
Via ACCESS Newswire
News headline image
AimwellBio Continues Onboarding Healthcare Professionals to Its Verified Observer Network, Adds One-Click LinkedIn Signup
From Aimwell Partners
Via ACCESS Newswire
News headline image
AIMN: As Healthcare Breaches Hit a Record and Move to Third-Party Providers, AimwellBio.com Explores a Redundancy Layer Built to Survive the Vendor
From Aimwell Partners
Via ACCESS Newswire
News headline image
AimwellBio Expands Platform Capabilities to Strengthen the Infrastructure Behind Trusted Healthcare Intelligence
From Aimwell Partners
Via ACCESS Newswire
News headline image
AimwellBio Opens Verified Observer Network to Healthcare, Research, and Capital Professionals at No Cost
Via ACCESS Newswire
News headline image
The Question No Telehealth Underwriter Wants Asked: When was Your Platform Last Breached, and Would You Even Know?
Via ACCESS Newswire
News headline image
As Healthcare's Software Leaders Race to Add AI, AimwellBio.com Moves to Build the Layer That Verifies It
Via ACCESS Newswire
News headline image
AimwellBio Opens a Door Most People Will Not Be Allowed Through, And Healthcare's Sharpest Professionals Are Already Walking In
Via ACCESS Newswire

Frequently Asked Questions

Is AIMN publicly traded?
Yes, AIMN is publicly traded.
What exchange does AIMN trade on?
AIMN trades on the OTC Traded
What is the ticker symbol for AIMN?
The ticker symbol for AIMN is AIMN on the OTC Traded
What is the current price of AIMN?
The current price of AIMN is 0.0015
When was AIMN last traded?
The last trade of AIMN was at 10/20/26 11:24 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.